Multisystem Inflammatory Syndrome in Children with COVID-19-Positive Antibodies
The epidemiology of multisystem inflammatory syndrome in children (MIS-C) and the provisional case definition are still being updated by the WHO. There is no solid evidence regarding the clinical presentations, severity, and outcomes. This case report tackles a 4-year-old female. Her main manifestat...
Saved in:
| Main Authors: | Bushra Yacop, Mustafa Helmi, Maysa Saleh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Knowledge E
2021-09-01
|
| Series: | Dubai Medical Journal |
| Subjects: | |
| Online Access: | https://www.karger.com/Article/FullText/518435 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Intrauterine onset of multisystem inflammatory syndrome in a neonate temporally associated with maternal COVID-19
by: U S Nitya, et al.
Published: (2022-01-01) -
Profile of Multisystem Inflammatory Syndrome in Children related to COVID-19: A Multicentric Study from South India
by: Sagar Bhattad, et al.
Published: (2023-06-01) -
Infliximab in treatment of refractory multisystem inflammatory syndrome in children with severe cardiac dysfunction
by: Guruprasad Hassan Shankar, et al.
Published: (2022-01-01) -
Features of laboratory parameters in children with multisystem inflammatory syndrome associated with SARS-CoV-2
by: O. O. Obukhova, et al.
Published: (2022-10-01) -
Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2 IgG in Juba, South Sudan, 20201
by: Andrew, Baguma, et al.
Published: (2021)